EcoDrugPlus

Ensembl ID : ENSCSEG00000004093
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSCSEG00000008145
Gene Symbol: -
Cross references: -
401 Possible Orthologues:

Ensembl ID : ENSCSEG00000002948
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSCSEG00000004103
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSCSEG00000006627
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSCSEG00000001688
Gene Symbol: -
Cross references: -
217 Possible Orthologues:

Ensembl ID : ENSCSEG00000018756
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSCSEG00000001338
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSCSEG00000004289
Gene Symbol: -
Cross references: -
258 Possible Orthologues:

Ensembl ID : ENSCSEG00000002943
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSCSEG00000007349
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSCSEG00000016715
Gene Symbol: -
Cross references: -
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).